Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PARM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
EIF3B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TSC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BID - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GGT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
TNIP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ABL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PHPT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HDAC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HTT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OBSCN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARL6IP5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDCD6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM193A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IDH3G - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RABGAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HOMER3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CREBBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on